Search

everythinglearnresearchcommunity

for

Search:↓

Cicatricial alopecia causes permanent hair loss and is treated to relieve symptoms and stop progression.

Most patients with alopecia areata in China have patchy hair loss, with total hair loss being less common, and the condition often starts around age 35 and can negatively affect quality of life, especially in more severe cases.

Alopecia areata has different forms and can significantly affect quality of life, especially in more severe cases.

The study concluded that patients with total hair loss and recurring hair loss had an earlier onset, longer-lasting condition, and a greater negative impact on their quality of life, with allergic conditions linked to more severe hair loss.

Babies born after 38 weeks to mothers under 36 years old and not delivered by C-section have a higher risk of neonatal occipital alopecia.

Hair loss in twins may be linked to family history of hair loss, high blood pressure, heart disease, and possibly anxiety, but more research is needed.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Zinc is effective for treating various skin conditions, including warts and acne.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Type 2 diabetes, bacterial scalp infections, and tight hairstyles like braids and weaves are linked to a higher risk of a scarring hair loss condition in African American women.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Doctors need to be better prepared to assess and treat obesity in patients.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

The document concludes that mouse models are crucial for studying hair biology and that all mutant mice may have hair growth abnormalities that require detailed analysis to identify.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

Loose anagen hair syndrome, often affecting young girls, can be diagnosed with a hair-pull test and usually gets better on its own, but severe cases may need treatment.

A systematic approach is crucial for managing hair loss in women.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.